Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

A population model of prostate cancer incidence. Stat Med 2006 Aug 30;25(16):2846-66 PMID: 16397859

Pubmed ID

16397859

Abstract

Introduction of screening for prostate cancer using the prostate-specific antigen (PSA) marker of the disease led to remarkable dynamics of the incidence of the disease observed in the last two decades. A statistical model is used to provide a link between dissemination of PSA and the observed transient population responses. The model is used to estimate lead time, overdiagnosis and other relevant characteristics of prostate cancer screening.

Author List

Tsodikov A, Szabo A, Wegelin J

Author

Aniko Szabo PhD Associate Professor in the Institute for Health and Equity department at Medical College of Wisconsin




Scopus

2-s2.0-33746903130   39 Citations

MESH terms used to index this publication - Major topics in bold

Age of Onset
Aged
Biometry
Humans
Male
Mass Screening
Middle Aged
Models, Statistical
Population
Prostate-Specific Antigen
Prostatic Neoplasms
SEER Program
Time Factors
United States
jenkins-FCD Prod-299 9ef562391eceb2b8f95265c767fbba1ce5a52fd6